$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll

$gtll Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019084 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$606.2K	$451.5K
YoY Change	20106.0%
Cost Of Revenue	$212.4K	$364.2K
YoY Change
Gross Profit	$393.8K	$87.31K
YoY Change	13025.0%
Gross Profit Margin	64.96%	19.34%
Selling, General & Admin	$187.1K	$62.98K	$4.497K
YoY Change	62.58%	1300.51%	-96.33%
% of Gross Profit	47.52%	72.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.280K	$9.273K	$1.298K
YoY Change	229.23%	614.41%	-0.15%
% of Gross Profit	1.09%	10.62%
Operating Expenses	$191.4K	$113.3K	$46.30K
YoY Change	64.44%	144.64%	-62.63%
Operating Profit	$202.4K	-$25.95K	-$46.30K
YoY Change	-278.46%	-43.95%	-58.86%
Interest Expense	-$10.72K	$2.500M	-$622.1K
YoY Change	-50.23%	-501.85%	199.5%
% of Operating Profit	-5.3%
Other Income/Expense, Net		$2.783M	-$622.1K
YoY Change		-547.34%	129.77%
Pretax Income	$285.9K	$2.757M	-$668.4K
YoY Change	-158.35%	-512.47%	74.38%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$285.9K	$2.757M	-$668.4K
YoY Change	-158.35%	-512.47%	74.38%
Net Earnings / Revenue	47.16%	610.6%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	14.69B shares	14.69B shares	14.49B shares
Diluted Shares Outstanding		14.69B shares	14.49B shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$115.8K	$144.6K	$0.00
YoY Change	532.51%		-100.0%
Cash & Equivalents	$115.7K	$144.6K
Short-Term Investments
Other Short-Term Assets	$225.0K
YoY Change
Inventory
Prepaid Expenses	$225.0K
Receivables	$184.7K	$126.7K	$5.000K
Other Receivables	$0.00	$0.00	$17.53K
Total Short-Term Assets	$525.4K	$271.3K	$43.19K
YoY Change	2771.25%	528.05%	-94.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$126.6K	$130.9K	$19.05K
YoY Change	613.2%	587.05%	-21.41%
Goodwill	$7.686M	$7.686M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.837M	$7.842M	$369.1K
YoY Change	23829.05%	2024.78%
Total Long-Term Assets	$7.837M	$7.842M	$369.1K
YoY Change	23829.05%	2024.78%	-50.63%
TOTAL ASSETS
Total Short-Term Assets	$525.4K	$271.3K	$43.19K
Total Long-Term Assets	$7.837M	$7.842M	$369.1K
Total Assets	$8.363M	$8.113M	$412.2K
YoY Change	16280.71%	1867.97%	-72.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$90.79K	$85.94K	$52.69K
YoY Change	186.78%	63.09%	1217.33%
Accrued Expenses	$144.0K	$227.5K	$105.0K
YoY Change	92.02%	116.67%	199.63%
Deferred Revenue
YoY Change
Short-Term Debt	$503.3K	$513.1K	$307.6K
YoY Change	28.3%	66.78%	-28.34%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.830M	$6.919M	$1.653M
YoY Change	306.66%	318.55%	41.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.830M	$6.919M	$1.653M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.830M	$6.919M	$1.653M
YoY Change	306.66%	318.55%	41.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$166.7M	-$167.0M	-$167.0M
YoY Change	-0.48%	-0.02%
Common Stock	$162.9M	$161.1M	$164.4M
YoY Change	0.9%	-2.0%
Preferred Stock	$1.861M	$1.827M	$1.385M
YoY Change	26.41%	31.92%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.532M	-$630.9K	-$1.241M
YoY Change
Total Liabilities & Shareholders Equity	$8.363M	$8.113M	$412.2K
YoY Change	16280.71%	1867.97%	-72.09%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$285.9K	$2.757M	-$668.4K
YoY Change	-158.35%	-512.47%	74.38%
Depreciation, Depletion And Amortization	$4.280K	$9.273K	$1.298K
YoY Change	229.23%	614.41%	-0.15%
Cash From Operating Activities	$101.2K	$35.30K	-$5.450K
YoY Change	-261.73%	-747.71%	-96.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-130.0K	98.58K	5.390K
YoY Change	-235.64%	1728.94%	-97.88%
NET CHANGE
Cash From Operating Activities	101.2K	35.30K	-5.450K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	-130.0K	98.58K	5.390K
Net Change In Cash	-28.83K	133.9K	-60.00
YoY Change	-257.63%	-223233.33%	-100.54%
FREE CASH FLOW
Cash From Operating Activities	$101.2K	$35.30K	-$5.450K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q1	us-gaap	Gross Profit GrossProfit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2024Q1	GTLL	Warehouse Building WarehouseBuilding		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent		usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	GTLL	Exchange Shares To Be Issued ExchangeSharesToBeIssued		usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	GTLL	Debt Instrument Forgiveness DebtInstrumentForgiveness		usd
	GTLL	Debt Instrument Forgiveness DebtInstrumentForgiveness		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	GTLL	Accrual For Contingent Consideration Of Acquisition AccrualForContingentConsiderationOfAcquisition		usd
	GTLL	Issuance Of Common Stock For Debt And Accrued Interest IssuanceOfCommonStockForDebtAndAccruedInterest		usd
	GTLL	Issuance Of Preferred Stock For Asset Purchase IssuanceOfPreferredStockForAssetPurchase		usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-25668
	dei	Entity Registrant Name EntityRegistrantName	GLOBAL TECHNOLOGIES, LTD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0970492
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 Campus Drive Suite 105
CY2024Q1	us-gaap	Assets Current AssetsCurrent	271263	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	18300	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30480	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18611	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130883	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17752	usd
CY2023Q2	GTLL	Warehouse Building WarehouseBuilding	15000	usd
	GTLL	Consulting Services ConsultingServices	252818	usd
	GTLL	Consulting Services ConsultingServices	500	usd
CY2024Q1	GTLL	Temporary Equity Issued Upon Conversion Value TemporaryEquityIssuedUponConversionValue	1825000	usd
CY2023Q2	GTLL	Temporary Equity Issued Upon Conversion Value TemporaryEquityIssuedUponConversionValue	2899488	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1825000	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2899488	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	161073727	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	159999238	usd
CY2024Q1	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	1827285	usd
CY2023Q2	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	1472285	usd
CY2024Q1	GTLL	Exchange Shares To Be Issued ExchangeSharesToBeIssued	1921409	usd
CY2024Q1	GTLL	Common Stock To Be Issued Value CommonStockToBeIssuedValue	30000	usd
CY2023Q2	GTLL	Common Stock To Be Issued Value CommonStockToBeIssuedValue	30000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166952147	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167478377	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-630878	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4528007	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8112782	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51052	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	451509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	451509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	364199	usd
	us-gaap	Cost Of Revenue CostOfRevenue	364199	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	87310	usd
	us-gaap	Gross Profit GrossProfit	87310	usd
	us-gaap	Gross Profit GrossProfit	14000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	20000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20000	usd
CY2024Q1	us-gaap	Officers Compensation OfficersCompensation	25000	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	20000	usd
	us-gaap	Officers Compensation OfficersCompensation	75000	usd
	us-gaap	Officers Compensation OfficersCompensation	354467	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	250000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2024Q1	GTLL	Consulting Services ConsultingServices	2818	usd
CY2023Q1	GTLL	Consulting Services ConsultingServices	500	usd
CY2024Q1	us-gaap	Depreciation Depreciation	9273	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1298	usd
	us-gaap	Depreciation Depreciation	11869	usd
	us-gaap	Depreciation Depreciation	3894	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	13185	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	20000	usd
	us-gaap	Professional Fees ProfessionalFees	39727	usd
	us-gaap	Professional Fees ProfessionalFees	47800	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62981	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4497	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	122236	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17166	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	113257	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	46295	usd
	us-gaap	Operating Expenses OperatingExpenses	501650	usd
	us-gaap	Operating Expenses OperatingExpenses	423827	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25947	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-46295	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-414340	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-409827	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4315	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13137	usd
CY2024Q1	GTLL	Debt Instrument Forgiveness DebtInstrumentForgiveness	102616	usd
	GTLL	Debt Instrument Forgiveness DebtInstrumentForgiveness	102616	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	180378	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	180378	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2543902	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-619005	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1545336	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-74988	usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	44049	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7397	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	195157	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	22573	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	692603	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49863	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2782847	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-622087	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	940570	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-134287	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2756900	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-668382	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	526230	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-544114	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2756900	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-668382	usd
	us-gaap	Net Income Loss NetIncomeLoss	526230	usd
	us-gaap	Net Income Loss NetIncomeLoss	-544114	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14688440097	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14688440097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14488440097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14488440097	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14675537875	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14675537875	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14418436085	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14418436085	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-947748	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	251098	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-59456	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-756106	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	183724	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572382	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-668382	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1240764	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4528007	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	250000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1224822	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3053185	usd
CY2023Q4	GTLL	Stock Cancelled During Period Value Preferred Stock Compensation StockCancelledDuringPeriodValuePreferredStockCompensation	-30000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	30000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-500512	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-3455492	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7009189	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7009189	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1575002	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	125000	usd
CY2024Q1	GTLL	Stock Issued Exchange Of Shares To Be Issued StockIssuedExchangeOfSharesToBeIssued	1921409	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2756900	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2756900	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-630878	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-630878	usd
	us-gaap	Net Income Loss NetIncomeLoss	526230	usd
	us-gaap	Net Income Loss NetIncomeLoss	-544114	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	25000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1545336	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-74988	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	180378	usd
	us-gaap	Depreciation Depreciation	11869	usd
	us-gaap	Depreciation Depreciation	3894	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	250000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	692603	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49863	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	126688	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	13137	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-847	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	54282	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	37131	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	94161	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	22573	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	58333	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	38074	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-139924	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-329881	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	186199	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	45000	usd
	GTLL	Borrowings From Loans Payable Officer BorrowingsFromLoansPayableOfficer	5000	usd
	GTLL	Borrowings From Loans Payable Officer BorrowingsFromLoansPayableOfficer	5387	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	30000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	266199	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5387	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	126275	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-324494	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18300	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	324494	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	144575	usd
	GTLL	Accrual For Contingent Consideration Of Acquisition AccrualForContingentConsiderationOfAcquisition	5764227	usd
	GTLL	Issuance Of Common Stock For Debt And Accrued Interest IssuanceOfCommonStockForDebtAndAccruedInterest	251098	usd
	GTLL	Issuance Of Preferred Stock For Asset Purchase IssuanceOfPreferredStockForAssetPurchase	125000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_800_eus-gaap--BasisOfAccounting_zzFmHDt4NCR" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_82D_zt5pXWkjpGib">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2024 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the nine months ended March 31, 2024 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2023 as filed with the Securities and Exchange Commission on December 29, 2023. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2023, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Cash Cash	144575	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zg7GIBBH7vda" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zgqUSfTMvlrb">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Accounts Receivable</span> </i>– On March 31, 2024 and June 30, 2023, the Company had $<span id="xdx_906_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20240331_zOfbXNRqq9Sl" title="Accounts receivables">126,688</span> and $<span id="xdx_900_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20230630_zbWNkNgchqxe" title="Accounts receivables"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span> in accounts receivable, respectively. All of the accounts receivable at March 31, 2024 was from one customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the nine months ended March 31, 2024 and 2023, the Company generated $<span id="xdx_90A_eus-gaap--Revenues_c20230701__20240331_zwRr0pkByz12" title="Revenues">451,509</span> and $<span id="xdx_90C_eus-gaap--Revenues_c20220701__20230331_z4DKpR1mhDtg" title="Revenues">14,000</span> revenue, respectively. All of the Company’s revenue for the nine months ended March 31, 2024 was generated from one customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – The Company relies on a limited number of suppliers and contract manufacturers. In particular, 10 Fold Services relies upon two pharmaceutical companies to provide products for the sales generated through 10 Fold Services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	126688	usd
	us-gaap	Revenues Revenues	451509	usd
	us-gaap	Revenues Revenues	14000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21250000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33600000000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zU1Peb5SYCMh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zCykDP7pGoAe">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	126688	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	126688	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	36363	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	36363	usd
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	125000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30480	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18611	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130883	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17752	usd
	us-gaap	Depreciation Depreciation	11869	usd
	us-gaap	Depreciation Depreciation	3894	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	78069	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	2250	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	327947	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1180680	usd
	GTLL	Preferred Stock Rank Description PreferredStockRankDescription	All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law
CY2024Q1	GTLL	Stock Issued During Period Value Conversion Of Preferred Stock StockIssuedDuringPeriodValueConversionOfPreferredStock	1825000	usd
CY2024Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.0001
CY2024Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	18250000000	shares
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166952147	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-139924	usd

Files In Submission

Name	View Source	Status
0001493152-24-019084-index-headers.html	Edgar Link	pending
0001493152-24-019084-index.html	Edgar Link	pending
0001493152-24-019084.txt	Edgar Link	pending
0001493152-24-019084-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gtll-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
gtll-20240331_cal.xml	Edgar Link	unprocessable
gtll-20240331_def.xml	Edgar Link	unprocessable
gtll-20240331_lab.xml	Edgar Link	unprocessable
gtll-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll

2024 Q2 Form 10-Q Financial Statement

#000149315224019084 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTLL GLOBAL TECHNOLOGIES LTD Stock $gtll

2024 Q2 Form 10-Q Financial Statement

#000149315224019084 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll